ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,976Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 1187

$598K Total Retail Price of All Prescriptions

Rank: 127 out of 1187

469 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 469 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 469 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 8,756 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $79 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
LEVOTHYROXINE SODIUM 480 433 1 3
SIMVASTATIN 428 392 2 1
HYDROCODONE-ACETAMINOPHEN 353 339 S3 3 20
AMLODIPINE BESYLATE 332 315 4 2
FUROSEMIDE 313 253 5 8
LISINOPRIL 294 269 6 4
METOPROLOL TARTRATE 285 267 7 10
ATORVASTATIN CALCIUM 273 264 8 6
METOPROLOL SUCCINATE 246 233 9 11
METFORMIN HCL 208 193 10 7
OMEPRAZOLE 193 170 11 5
NEXIUM 183 126 12 15
HYDROCHLOROTHIAZIDE 182 174 13 9
SERTRALINE HCL 180 166 14 22
GLIMEPIRIDE 147 141 15 30
LOSARTAN POTASSIUM 124 124 16 21
ATENOLOL 119 83 17 18
DONEPEZIL HCL 119 119 17 26
CELEBREX 116 91 19 68
WARFARIN SODIUM 115 111 20 13
GABAPENTIN 108 85 21 23
MELOXICAM 92 85 22 49
DIGOXIN 88 83 23 65
CRESTOR 87 52 24 16
CARVEDILOL 84 79 25 19
PROAIR HFA 80 56 26 41
AZITHROMYCIN 80 72 26 24
ENALAPRIL MALEATE 78 78 28 27
RAMIPRIL 75 68 29 36
ZOLPIDEM TARTRATE 73 58 30 14
SYNTHROID 72 72 31 46
TAMSULOSIN HCL 72 61 31 29
PANTOPRAZOLE SODIUM 70 58 33 42
KLOR-CON 10 67 67 34 151
AMOXICILLIN 63 57 35 97
JANUVIA 62 60 36 34
KLOR-CON M20 59 49 37 93
PRAVASTATIN SODIUM 59 59 37 12
FENTANYL 58 27 S2 39 82
OXYCODONE-ACETAMINOPHEN 58 49 S2 39 47
DIOVAN 57 56 41 17
LIPITOR 55 50 42 43
FAMOTIDINE 53 51 43 48
SPIRIVA 51 39 44 55
SINGULAIR 50 24 45 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.